Hepatitis B in China

被引：288

作者：

Liu, Jie ^{[1
]}

Fan, Daiming ^{[1
]}

机构：

[1] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China

来源：

LANCET | 2007年 / 369卷 / 9573期

关键词：

D O I：

10.1016/S0140-6736(07)60723-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1582 / 1583

页数：2

共 11 条

[1]

[Anonymous], CLIN MED J

[2]

Cui FQ, 2006, CHIN J VACCINES IMMU, V12, P206

[3] Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised [J].

Janssen, HLA ;

van Zonneveld, M ;

Senturk, H ;

Zeuzem, S ;

Akarca, US ;

Cakaloglu, Y ;

Simon, C ;

So, TMJ ;

Gerken, G ;

de Man, RA ;

Niesters, HGM ;

Zondervan, P ;

Hansen, B ;

Schalm, SW .

LANCET, 2005, 365 (9454) :123-129

[4]

Jia Ji-dong, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P698

[5] Viral hepatitis B [J].

Lai, CL ;

Ratziu, V ;

Yuen, MF ;

Poynard, T .

LANCET, 2003, 362 (9401) :2089-2094

[6]

Liang Xiao-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P655

[7] The maze of treatments for hepatitis B [J].

Lok, AS .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2743-2746

[8] Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy [J].

Sung, JJY ;

Wong, ML ;

Bowden, S ;

Liew, CT ;

Hui, AY ;

Wong, VWS ;

Leung, NWY ;

Locarnini, S ;

Chan, HLY .

GASTROENTEROLOGY, 2005, 128 (07) :1890-1897

[9]

Wang X.J., 2004, DIS SURVEILLANCE, V19, P290

[10]

Zhuang H, 2005, CHIN J INFECT DIS S, V23, P2

← 1 2 →